Dr Layla Hosseini-Gerami speaks at Fierce Pharma Engage in San Diego.
Layla discussed:
- How AI is proactively sourcing assets—creating data-driven, de-risked deal flow.
- How AI can help fix toxicity issues to reposition high-potential but previously failed drugs.
- How to cut through the noise: what BD&L teams and investors should really look for in AI platforms.
